Skip to main content

Advertisement

Log in

Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Hereditary coagulation factor XI (FXI) deficiency is a rare bleeding disorder, but information on FXI deficiency in Taiwanese patients remains scarce. We evaluated clinical and genetic features of severe FXI deficiency patients in Taiwan. We collected clinical information and performed coagulation laboratory tests and genetic studies in ten unrelated Taiwanese families with severe FXI deficiency. FXI coagulation activity was assayed using a one-stage method. FXI antigen was determined using enzyme-linked immunosorbent assay. Underlying genetic mutations were evaluated using direct sequencing methods. Ten unrelated Taiwanese patients with hereditary FXI deficiency and variable bleeding tendencies were analyzed. Half of the patients were male. The most common bleeding manifestations were easy bruising (40%), bleeding after dental procedures (40%), and postoperative bleeding (33%). Two patients (20%) were asymptomatic. No correlation was found between bleeding manifestations and baseline FXI levels. Three novel mutations were identified: c.1322delT p.Lys442Cysfs*8, c.599G > C p.Cys200Ser, and IVS4 c.325 + 2del124. Two common mutations, c.1107C > T p.Tyr369* (40%) and c.841C > T p.Gln281* (30%), were also found. No correlation existed between bleeding and FXI activity, highlighting the difficulty in predicting FXI deficiency-related bleeding. Three novel FXI genetic mutations and two common mutations were identified, contributing to the known spectrum of FXI deficiency-related mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Emsley J, McEwan PA, Gailani D. Structure and function of factor XI. Blood. 2010;115:2569–77.

    Article  CAS  Google Scholar 

  2. Bouma BN, Meijers JC. Role of blood coagulation factor XI in downregulation of fibrinolysis. Curr Opin Hematol. 2000;7:266–72.

    Article  CAS  Google Scholar 

  3. Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953;82:171–4.

    Article  CAS  Google Scholar 

  4. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds–a clinical and laboratory study. ThrombHaemost. 1995;73:194–202.

    CAS  Google Scholar 

  5. Brenner B, Laor A, Lupo H, Zivelin A, Lanir N, Seligsohn U. Bleeding predictors in factor-XI-deficient patients. Blood Coagul Fibrinolysis. 1997;8:511–5.

    Article  CAS  Google Scholar 

  6. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985;65:719–24.

    Article  CAS  Google Scholar 

  7. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood. 1978;51:1223–8.

    Article  CAS  Google Scholar 

  8. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995;85:429–32.

    Article  CAS  Google Scholar 

  9. World Federation of Hemophilia. Report on the annual global survey 2017. Montréal: World Federation of Hemophilia; 2018.

    Google Scholar 

  10. Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10:615–21.

    Article  CAS  Google Scholar 

  11. Martincic D, Kravtsov V, Gailani D. Factor XI messenger RNA in human platelets. Blood. 1999;94:3397–404.

    Article  CAS  Google Scholar 

  12. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564–9.

    Article  Google Scholar 

  13. Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry. 1987;26:7221–8.

    Article  CAS  Google Scholar 

  14. Peyvandi F, Di Michele D, Bolton-Maggs PH, Lee CA, Tripodi A, Srivastava A. Project on Consensus Definitions in Rare Bleeding Disorders of the factor VIII/factor IX Scientific and Standardisation Committee of the Internaltional Society on Thrombosis and Haemostasis. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost. 2012;10:1938–43.

    Article  CAS  Google Scholar 

  15. Santoro C, Di Mauro R, Baldacci E, De Angelis F, Abbruzzese R, Barone R, et al. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre. Haemophilia. 2015;21:196–501.

    Article  Google Scholar 

  16. Drakulic M, Chai-Adisaksopha C, Iorio A. Clinical and biological determinants of bleeding manifestation in congenital factor XI deficiency; a systematic review. Blood. 2016;128:1407.

    Article  Google Scholar 

  17. Puy C, Rigg RA, McCarty OJ. The hemostatic role of factor XI. Thromb Res. 2016;141(Suppl 2):S8–S11.

    Article  CAS  Google Scholar 

  18. Key NS. Epidemiologic and clinical data linking factors XI and XII to thrombosis. Hematology Am Soc Hematol Educ Program. 2014;2014:66–70.

    Article  Google Scholar 

  19. Kato A, Asakai R, Davie EW, Aoki N. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet. 1989;52:77–8.

    Article  CAS  Google Scholar 

  20. Mitchell M, Mountford R, Butler R, Alhaq A, Dai L, Savidge G, et al. Spectrum of factor XI (F11) mutations in the UK population–116 index cases and 140 mutations. Hum Mutat. 2006;27:829.

    Article  Google Scholar 

  21. Bolton-Maggs PH, Butler R, Mountford R, Gailani D. Eleven novel mutations in non-Jewish factor XI deficient kindreds detected by SSCP with heteroduplex analysis followed by sequencing. J Thromb Haemost. 2003;1(Suppl. 1):P1687.

    Article  Google Scholar 

  22. O'Connell NM, Saunders RE, Lee CA, Perry DJ, Perkins SJ. Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J Thromb Haemost. 2005;3:127–38.

    Article  CAS  Google Scholar 

  23. Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. PNAS. 2011;108:11093–8.

    Article  CAS  Google Scholar 

  24. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci U S A. 1989;86:7667–711.

    Article  CAS  Google Scholar 

  25. Au WY, Cheung JW, Lam CC, Kwong YL. Two factor XI mutations in a Chinese family with factor XI deficiency. Am J Hematol. 2003;74:136–8.

    Article  CAS  Google Scholar 

  26. Kawaguchi T, Koga S, Hongo H, Komiyama Y, Li K, Ishihara S, et al. A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription. Int J Hematol. 2000;71:84–9.

    CAS  PubMed  Google Scholar 

  27. Sato E, Kawamata N, Kato A, Oshimi K. A novel mutation that leads to a congenital factor XI deficiency in a Japanese family. Am J Hematol. 2000;63:165–9.

    Article  CAS  Google Scholar 

  28. Kim J, Song J, Lyu CJ, Kim YR, Oh SH, Choi YC, et al. Population-specific spectrum of the F11 mutations in Koreans: evidence for a founder effect. Clin Genet. 2012;82:180–6.

    Article  CAS  Google Scholar 

  29. Shao Y, Cao Y, Lu Y, Dai J, Ding Q, Wang X, et al. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China. Blood Cells Mol Dis. 2016;58:29–34.

    Article  CAS  Google Scholar 

  30. Okumura K, Kyotani M, Kawai R, Takagi A, Murate T, Yamamoto K, et al. Recurrent mutations of factor XI gene in Japanese. Int J Hematol. 2006;83:462–3.

    Article  CAS  Google Scholar 

  31. Wu WM, Wang HL, Wang XF, Chu HY, Fu QH, Ding QL, et al. Identification of two novel factor XI non-sense mutation Trp228stop and Trp383stop in a Chinese pedigree of congenital factor XI deficiency. Zhonghua Xue Ye Xue Za Zhi. 2003;24:126–8.

    CAS  PubMed  Google Scholar 

  32. Saunder RE, Shiltagh N, Gomez K, Mellars G, Cooper C, Gomez K, et al. Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency. Thromb Haemost. 2009;102:287–301.

    Article  Google Scholar 

  33. Guella I, Solda G, Spena S, Asselta R, Ghiotto R, Tenchini ML, et al. Molecular characterization of two novel mutations causing factor XI deficiency: a splicing defect and a missense mutation responsible for a CRM+ defect. Thromb Haemost. 2008;99:523–30.

    Article  CAS  Google Scholar 

  34. Asselta R, Paraboschi EM, Rimoldi V, Menegatti M, Peyvandi F, Salomon O, et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood. 2017;130:e1–e6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Ming-Ching Shen designed the research and supervised the study. Hsuan-Yu Lin analyzed the data, interpreted the data, and wrote the paper. Ching-Yeh Lin gathered the data. Mei-Hua Hung performed experiments. Su-Feng Kuo performed experiments and measured FXI Ag levels. Jen-Shiou Lin analyzed and interpreted the experiment results.

Corresponding author

Correspondence to Ming-Ching Shen.

Ethics declarations

Conflict of interest

The authors stated that they had no interests which might be perceived as posing a conflict or bias.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, HY., Lin, CY., Hung, MH. et al. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations. Int J Hematol 112, 169–175 (2020). https://doi.org/10.1007/s12185-020-02883-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-020-02883-0

Keywords

Navigation